15 Jan 2019 07:00
Spire Healthcare Group plc
("Spire" or the "Company")
Post-close trading update
15 January 2019
Spire Healthcare Group plc (LSE: SPI), a leading UK independent hospital group, is pleased to provide a trading update for the financial year ended 31 December 2018. The Company expects to report revenue of c.£931 million and EBITDA before exceptional and other items of between £119 and £120 million.
Spire's cash position has improved year-on-year following continued strong cash conversion, with net debt reduced to approximately £457 million and a year end net debt to EBITDA ratio of less than 3.7 times.
The Company achieved good strategic progress during 2018. As at 31 December 2018 76% of Spire's hospitals were rated Outstanding or Good by the CQC, up from 67% at the previous year end. There was also momentum in private payor growth.
Spire will announce Full Year Results on 28 February 2019 together with strategic and operational progress reports and guidance for the current financial year.
-ends-
For further information please contact:
Spire Healthcare Jitesh Sodha, Chief Financial Officer Antony Mannion, Investor Relations Director
| +44 (0)20 7427 9160
|
Instinctif Damian Reece Guy Scarborough | +44 (0)20 7457 2020
|
REGISTERED OFFICE AND HEAD OFFICE:
Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN
Registered number: 09084066
Spire Healthcare (SPI)